Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

Gufic Biosciences Ltd - 509079 - Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s

 Re-appointment of M/s. SHR & Co., Chartered Accountants (Registration No. ICAI FRN 120491W) as Statutory Auditors of the Company to hold office for a term of four consecutive years from the conclusion of the ensuing 35th Annual General Meeting until the conclusion of the 39th Annual General Meeting of the Company, subject to the approval of the shareholders at the ensuing Annual General Meeting. Pursuant to SEBI Circular CIR/CFD/CMD/4/2015 dated September 9, 2015 a brief profile of M/s. SHR & Co., is enclosed herewith.
13-08-2019
Bigul

Gufic Biosciences Ltd - 509079 - Unaudited Financial Results For The Quarter Ended June 30,2019

 The Board of Directors at its Meeting held on August 13, 2019 approved the Un-Audited Financial Results for the quarter ended June 30, 2019 pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
13-08-2019
Bigul

GUFIC BIOSCIENCES LTD. - 509079 - Unaudited Financial Results For The Quarter Ended June 30,2019

 The Board of Directors at its Meeting held on August 13, 2019 approved the Un-Audited Financial Results for the quarter ended June 30, 2019 pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
13-08-2019
Bigul

Gufic Biosciences Ltd - 509079 - Corporate Action-Board to consider Dividend

 The Board of Directors at its Meeting scheduled to be held on Tuesday, August 13, 2019, inter alia shall consider declaration of Interim dividend, if any, to the Equity Shareholders of the Company
08-08-2019
Bigul

GUFIC BIOSCIENCES LTD. - 509079 - Board Meeting Intimation for Consideration And Approval Of The Unaudited Financial Results Of The Company For The Quarter Ended June 30, 2019

 GUFIC BIOSCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2019 ,inter alia, to consider and approve Pursuant to the provisions of Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that a meeting of Board of Directors of the Company is scheduled to be held on Tuesday, August 13, 2019, inter alia to consider and approve the Unaudited Financial Results of the Company for the quarter ended June 30, 2019. The Trading Window in respect of dealing in the Equity Shares of the Company, has remained closed for all the Directors and designated (specified) employees of the Company, with effect from July 01, 2019 until 48 hours after declaration of the Financial Results of the Company for the Quarter ended June 30, 2019. The Trading window in respect of dealing in the Shares of the Company shall reopen on August 16, 2019. Kindly take the same on record.
06-08-2019
Bigul

GUFIC BIOSCIENCES LTD. - 509079 - Intimation Of Appointment Of Mr. Satyen Manikani As A Senior Vice President - Strategy And Business Development Of The Company

 In order to sharpen the vision and ensure precise execution of the strategy adopted by the Company, the Company have recently appointed Mr. Satyen Manikani as a Senior Vice President - Strategy and Business Development of the Company. His brief profile is enclosed herewith, for your reference. You are requested to take the same on record.
05-08-2019
Bigul

GUFIC BIOSCIENCES LTD. - 509079 - Gufic Biosciences Limited To Launch Botulinum Neuromedicine

 Pursuant to Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 enclosed herewith the Press Release on the above mentioned subject being released by the Company. Kindly take the same on your record.
18-07-2019
Bigul

Gufic Biosciences Ltd - 509079 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 This is to certify that the securities received for dematerialization during the quarter ended June 30, 2019, as required under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018, have been furnished to all the stock exchanges where the shares of the Company are listed. The letter confirming the above as received from our Registrar and Share Transfer Agent, M/s Link Intime India Private Limited is enclosed herewith. Kindly take the same on your record
15-07-2019
Bigul

GUFIC BIOSCIENCES LTD. - 509079 - Shareholding for the Period Ended June 30, 2019

 Gufic Biosciences Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2019. For more details, kindly Click here
10-07-2019
Bigul

Gufic Biosciences Ltd - 509079 - Statement Of Investor Complaints For The Quarter Ended June 2019

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Ami ShahDesignation :- Company Secretary and Compliance Officer
08-07-2019
Next Page
Close

Let's Open Free Demat Account